Abstract. Previous work has shown that the Smilacis chinae rhizome (SCR) markedly inhibits amyloid β protein (25-35)-induced neuronal cell damage in cultured rat cortical neurons. The present study was conducted to further verify the neuroprotective effect of SCR on excitotoxic and cerebral ischemic injury using both in vitro and in vivo studies. Exposure of cultured cortical neurons to 1 mM N-methyl-D-aspartate (NMDA) for 12 h induced neuronal cell death. SCR (10 and 50 µg / ml) inhibited NMDA-induced neuronal death, elevation of intracellular calcium ([Ca 2+ ] i ), and generation of reactive oxygen species (ROS) in primary cultures of rat cortical neurons. In vivo, SCR prevented cerebral ischemic injury induced by 3-h middle cerebral artery occlusion (MCAO) and 24-h reperfusion. The ischemic infarct was significantly reduced in rats that received SCR (30 and 50 mg / kg, orally), with a corresponding improvement in neurological function. Moreover, SCR treatment significantly decreased the histological changes observed following ischemia. Oxyresveratrol and resveratrol isolated from SCR also inhibited NMDAinduced neuronal death, increase in [Ca 2+ ] i , and ROS generation in cultured cortical neurons, suggesting that the neuroprotective effect of SCR may be attributable to these compounds. Taken together, these results suggest that the neuroprotective effect of SCR against focal cerebral ischemic injury is due to its anti-excitotoxic effects and that SCR may have a therapeutic role in neurodegenerative diseases such as stroke.
Introduction
Ischemic stroke, one of the leading causes of death and long-lasting disability, results from a transient or permanent reduction in cerebral blood flow in a major brain artery (1, 2) . Reduction of flow is, in most cases, caused by the occlusion of a cerebral artery either by an embolus or by local thrombosis. Focal impairment of cerebral blood flow restricts the delivery of metabolic substrates, particularly oxygen and glucose, leading to depletion of the energy stores required to maintain ionic gradients (3). With energy depletion, membrane potential is lost and neurons and glial cells depolarize (4) . Massive neuronal depolarization opens voltagesensitive Ca 2+ channels and leads to an extracellular buildup of excitatory amino acids, which overstimulate excitatory amino acid receptors (5) . Concomitantly, energy-dependent processes such as presynaptic reuptake of excitatory amino acids is impeded, which further increases the accumulation of glutamate in the extracellular space. Acute elevation of glutamate activates glutamate receptors of which the N-methyl-Daspartate (NMDA) and α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors are clearly implicated in neurotoxicity.
Glutamate is the major excitatory neurotransmitter as well as an important neurotoxin in the CNS. In most cases, exposure to agonists of NMDA receptors leads to increased cell death, whereas antagonists are protective (6, 7) . Neurotoxicity initiated by overstimulation of NMDA receptors and subsequent influx of free Ca
2+
leads to an intracellular cascade of cytotoxic events (8) . Ca
-dependent depolarization of mitochondria may contribute to oxidative stress in neuronal injury through production of reactive oxygen species (ROS) such as hydroxyl radicals, superoxide anions or nitric oxide, producing lipid peroxidation and membrane damage (9, 10) . The key role of ROS in cell damage associated with stroke is underlined by the fact that even delayed treatment with free-radical scavengers can be effective in experimental focal cerebral ischemia (11) . In vitro NMDA neurotoxicity models have also been widely used to elucidate the mechanism of responses to brain ischemia (12, 13) .
Smilax china belongs to the Liliaceae family and is widely distributed in China, Japan, the Philippines, and Korea. The Smilacis chinae rhizome (SCR) has antimicrobial, antimutagenic, and antioxidant activities (14 -16) . SCR was recently reported to have antiinflammatory and anti-nociceptive activities as well (17) . In a previous report, we demonstrated a significant neuroprotective effect of SCR against amyloid β protein (25-35)-induced neuronal cell damage in cultured rat cortical neurons (18) . In the current study, we investigated the protective effect of SCR against ischemiainduced brain infarction following middle cerebral artery occlusion (MCAO) in rats, as well as the effect of SCR on NMDA-induced neuronal damage using cultured rat cortical neurons, to elucidate the neuroprotective mechanism of SCR. In addition, active components contributing to the neuroprotective effect of SCR against NMDA-induced neurotoxicity were isolated.
Materials and Methods

Chemicals
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT), trypsin (from bovine pancreas), Dulbecco's modified Eagle's medium (DMEM), Joklikmodified MEM, poly-L-lysine, and 2,3,5-triphenyltetrazolium chloride (TTC) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). NMDA was purchased from RBI (Natick, MA, USA). Hoechst 33342, Fluo-4 AM, and 2',7'-dichlorodihydrofluorescin diacetate (H 2 DCF-DA) were purchased from Molecular Probes, Inc. (Eugene, OR, USA). Fetal bovine serum was purchased from JRH Biosciences (Lenexa, KS, USA). All other chemicals used were of the highest grade available.
Plant material, preparation, and identification SCR was purchased at an herbal medicine market in Daegu, Korea and identified by Dr. Jong-Hwan Kwak at Sungkyunkwan University, Suwon, Korea. A voucher specimen (No. SC-0401) has been deposited at The Innovative Research Laboratory of Natural Products Medicine, Kyungpook National University, Daegu, Korea.
Dried SCR (1.8 kg) was refluxed in methanol (2000 ml × 3) and the extract was evaporated to dryness for use in experiments. The yield was approximately 10% (w / w). The dried methanol extract (100 g) was suspended in water and consecutively partitioned with methylene chloride (CH 2 Cl 2 , 700 ml × 3) and ethyl acetate (EtOAc, 700 ml × 3). The EtOAc soluble fraction (6.9 g) was chromatographed on a Sephadex LH-20 column [4.0 × 68.0 cm (Pharmacia Biotech AB, Uppsala, Sweden); stepwise gradient of 50% to 100% methanol] to yield nineteen fractions (Fr. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . HPLC [µ-Bondapak C 18 , 7.8 × 300 mm (Waters, Milford, MA, USA); 1% acetic acid in 35% methanol; 1.5 ml / min] of Fr. 8 isolated 11.5 mg of resveratrol. Fr. 10 was rechromatographed through a silica gel column (1.4 × 40 cm, CH 2 Cl 2 -methanol-acetic acid = 30:1:1→ 1:1:1) and the resultant active fractions were separated by HPLC [Apollo C 18 , 10 × 250 mm (Alltech, Deerfield, IL, USA); 1% acetic acid in 33% and 38% methanol for Fr. 10-3 and Fr. 10-5, respectively] to isolate oxyresveratrol (4.0 mg).
Animals
Sprague-Dawley (SD) rats (Daehan Biolink Co., Ltd., Chungbuk, Korea) were housed in an environmentally controlled room at 22 ± 2°C, with a relative humidity of 55 ± 5%, a 12-h light / dark cycle, and food and water ad libitum. The procedures involving experimental animals complied with the regulations for the care and use of laboratory animals of the animal ethics committee of Chungbuk National University.
Induction of excitotoxicity in primary cultures of rat cerebral cortical neurons
Primary cortical neuron cultures were prepared using embryonic day 15 to 16 (E15 -E16) SD rat fetuses, as described previously (18 -20) . Neurotoxicity experiments were performed on neurons after 5 -7 days in culture. Cultured neurons were treated with 1 mM NMDA in a HEPES-buffered solution containing 8.6 mM HEPES, 154 mM NaCl, 5.6 mM KCl, and 2.3 mM CaCl 2 , pH 7.4, for 12 h at 37°C. NMDA was solubilized in the same buffer. SCR and resveratrol were dissolved in methanol at a concentration of 50 mg / ml and 50 mM, respectively. Oxyresveratrol was dissolved in dimethylsulfoxide (DMSO) at a concentration of 20 mM. All compounds were further diluted in the HEPES buffer. The final concentration of methanol and DMSO was 0.1% or less, which did not affect cell viability. For each experiment, SCR, resveratrol, and oxyresveratrol were added 20 min prior to treatment with NMDA; and they were also present in the buffer during the NMDA incubation.
Analysis of neuronal viability
Neuronal viability was monitored using the colorimetric MTT assay, as previously described (18 -20) . After exposure to 1 mM NMDA for 12 h, the culture medium was replaced by a solution of MTT (0.5 mg / ml) in serum-free growth medium. After a 4-h incubation at 37°C, this solution was removed, the resulting blue formazan was solubilized in acidic isopropanol (0.04 N HCl in isopropanol), and the optical density was read at 570 nm using a microplate reader (EL X 808; Bio-tek, Vermont, VT, USA). Results are expressed as the percentage of MTT reduction, with the absorbance of control cells normalized to 100%. Apoptotic cell death was characterized using Hoechst 33342 staining (18 -20) . Neurons on coverslips exposed to 1 mM NMDA for 12 h were fixed in 4% paraformaldehyde at room temperature for 20 min and then stained with 1 µg / ml Hoechst 33342 in HEPES buffer for 15 min. The dye was excited at 340 nm, and emission was filtered with a 510-nm barrier filter under UV illumination using a fluorescence microscope (IX70-FL; Olympus, Tokyo). Neurons with fragmented or condensed DNA and normal DNA were counted and the data are presented as apoptotic neurons as a percentage of total neurons.
Measurement of intracellular Ca
] i ) Neurons grown on coverslips were loaded with 3 µM Fluo-4 AM (dissolved in DMSO) in serum-free growth medium for 45 min at 37°C in a CO 2 incubator and then washed with the HEPES buffer. Coverslips with Fluo-4 AM-labeled neurons were mounted in a perfusion chamber containing HEPES buffer and examined by laser scanning confocal microscopy (LSM 510; Carl Zeiss, Oberkochen, Germany). Samples were scanned every 5 s using a 488-nm excitation argon laser and a 515-nm longpass emission filter. After the baseline [Ca 
Measurement of ROS generation
A microfluorescence assay to detect 2',7'-dichlorofluorescin (DCF), the fluorescent product of H 2 DCF-DA, was used to monitor the generation of ROS. Neurons grown on coverslips were washed with phenol red-free DMEM 3 times and incubated with 1 mM NMDA in HEPES buffer at 37°C for 1 h. Neurons were incubated in 5 µM H 2 DCF-DA for the last 20 min of the NMDA incubation. After washing, coverslips containing cortical neurons loaded with H 2 DCF-DA were mounted and the neurons were observed using a laser scanning confocal microscope (MRC1024ES; Biorad, Maylands, UK) with 488-nm excitation and 510-nm emission filters. The average pixel intensity of the fluorescence was measured in each cell in the field and expressed in relative units of DCF fluorescence. Values for the average staining intensity per cell were obtained using the image analyzing software supplied by the manufacturer.
MCAO-induced focal cerebral ischemia in rats
Before surgery, male rats weighing 300 ± 10 g were fasted overnight with free access to water. Focal cerebral ischemia was produced by a modification of the monofilament method as described by Longa et al. (22) . Briefly, rats were anesthetized with isoflurane (initiated with 5% and maintained at 2%) in 25% O 2 / 75% N 2 . Rectal temperature was maintained at 37°C -38°C throughout the surgical procedure by covering the animals with a heating pad. The right carotid bifurcation was exposed through a midline neck incision, and a filament, with a rounded tip and a distal cylinder of silicon rubber (0.30 mm in diameter), was introduced into the external carotid artery. A suture was then inserted at least 20 mm from the carotid bifurcation and was withdrawn 3-h later to allow reperfusion. SCR (30 and 50 mg / kg) was orally administered three times: 0.5 h before occlusion, 1 h after occlusion, and 1 h after reperfusion.
Evaluation of ischemic damage
Measurement of infarct size: Animals were anesthetized with diethyl ether and sacrificed by decapitation 24 h after reperfusion. Brains were quickly removed and were cut into six coronal sections, 2-mm-thick, using a rat brain matrix (ASI ® Instruments, Inc., Warren, MI, USA). The sections were stained with 2% TTC in saline for 30 min at 37°C (23) and photographed. These images were analyzed using a computerized image analysis system (Optimas 6.1; Media Cybernetics, Silver Springs, MD, USA) to measure the infarct area. The infarct area in each slice was calculated by subtracting the normal ipsilateral area from that of the contralateral hemisphere to reduce errors due to cerebral edema and was presented as a percentage relative to the area of the contralateral hemisphere.
Neurological deficits: After 24 h of reperfusion, the neurological status of the animals was evaluated according to Menzies et al. (24) . Five categories were scored: 0 = no apparent deficits; 1 = contralateral forelimb flexion; 2 = decreased grip of contralateral forelimb while the tail was pulled; 3 = spontaneous movement in all directions, contralateral circling if pulled by the tail; 4 = spontaneous contralateral circling.
Histological examination: Twenty four hours after reperfusion, animals were anesthetized deeply with diethyl ether; and then the brains were perfused transcardially with cold heparinized phosphate-buffered saline (PBS, pH 7.2), removed, and fixed in 10% formalin in PBS for 24 h. The brains were then embedded in paraffin and representative coronal sections (6-µm-thick), which included the dorsal hippocampus, were obtained using a rotary microtome (Sakura Finetechnical Co., Ltd., Tokyo). Tissue sections were stained with hematoxylin and eosin (H-E). The sections were dehydrated, mounted in Canada balsam, and then analyzed using a brightfield microscope (IX70; Olympus, Tokyo).
Statistical analysis
Data were expressed as the mean ± S.E.M., and statistical significance was assessed by one-way analysis of variance (ANOVA) and Tukey's test. P<0.05 was considered to be significant.
Results
Protective effects of SCR and its active compounds against NMDA-induced neuronal cell death
The MTT assay was used to quantify cell death in response to NMDA treatment. When cerebral cortical neurons were exposed to 1 mM NMDA, MTT absorbance was 75.0 ± 1.5% of that of the untreated controls, indicating that NMDA caused neuronal cell death. In cultures treated with SCR (10 and 50 µg/ml), NMDAinduced cell death was significantly reduced (MTT, 108.0 ± 2.5% with 50 µg/ ml SCR). Hoechst 33342 staining was used to detect condensed or fragmented DNA, which was indicative of NMDA-induced neuronal apoptotic cell death. Treatment of neurons with 1 mM NMDA induced apoptosis in 19.5 ± 2.2% of cultured cortical neurons, compared to 3.1 ± 0.3% apoptotic neurons in control cultures. The addition of SCR (10 and 50 µg/ml) significantly decreased NMDA-induced apoptotic cell death to 9.5 ± 0.7% apoptotic cells in 50 µg/ml SCR (Fig. 1A) .
To determine which components of SCR exhibit neuroprotective activity, we isolated catechin, epicatechin, oxyresveratrol, resveratrol, 3,4-dihydroxybenzoic acid, and quercetin-3-O-alpha-rhamnopyranoside from SCR. Only oxyresveratrol and resveratrol showed protective effects against NMDA-induced neurotoxicity in cultured cortical neurons. Pretreatment of cerebral cortical neurons with 10 µM oxyresveratrol or resveratrol blocked the neurotoxic effects of exposure to 1 mM NMDA (MTT, 94.7 ± 3.2% and 105.9 ± 6.1%, respectively) in comparison to cerebral cortical neurons exposed to 1 mM NMDA alone (MTT, 63.0 ± 1.7%). Furthermore, we found that cortical neurons exposed to serum-deprived glucose-free HEPES buffer for 12 h showed a decrease in viability of 26.0 ± 2.1%. This decrease was completely recovered in the presence of 50 µM resveratrol (MTT, 135.5 ± 6.5%), indicating that resveratrol also inhibited neuronal cell death induced by the stress conditions of serum-deprived glucose-free HEPES buffer (Fig. 1B) . SCR, oxyresveratrol, and resveratrol did not affect cell viability (data not shown).
Inhibitory effects of SCR and its active compounds on NMDA-induced elevation of [Ca
] i may play a critical role in the early stages of NMDA-induced neurotoxicity. As shown in Fig. 2 
, [Ca
2+
] i rapidly increased in response to treatment with 1 mM NMDA and maintained a plateau for over 10 min. In contrast, pretreatment with SCR (50 µg/ ml), oxyresveratrol (10 µM), or resveratrol (50 µM) completely inhibited the NMDA-induced increase in [Ca 2+ ] i . SCR, oxyresveratrol, and resveratrol did not affect basal [Ca 2+ ] i (data not shown).
Inhibitory effect of SCR on NMDA-induced ROS generation
NMDA treatment increased the cytosolic concentration of free Ca
2+
. Furthermore, the pathological conditions induced by NMDA are associated with accelerated formation of ROS. In H 2 DCF-DA-loaded cerebral cortical neurons, 1 mM NMDA increased the fluorescence intensity, indicating the generation of ROS. In neurons treated with 1 mM NMDA for 1 h, the fluorescence intensity increased approximately 3-fold to 134.6 ± 8.7 compared to control neurons (46.7 ± 4.2). SCR (10 and 50 µg/ml), oxyresveratrol (1 and 10 µM), and resveratrol (10 and 50 µM) all significantly blocked the NMDA-induced increase in fluorescence intensity (Fig. 3) .
Neuroprotective effect of SCR on infarction in response to MCAO-induced focal cerebral ischemia MCAO for 3 h, followed by a 24-h reperfusion, resulted in a large ipsilateral cerebral infarction as shown in TTC-stained coronal sections of rat brain. Representative brain slices from control and SCRtreated rats show that the normal brain tissue was stained deep red, whereas the infarct tissue was not stained by TTC (Fig. 4A) . The infarction area in SCR treated rats was less than the area in non-SCR-treated controls. Figure 4B summarizes the effects of SCR (30 and 50 mg/kg) and MK-801, an NMDA-receptor antagonist, on cerebral infarction in this rat brain focal ischemia model. SCR (30 and 50 mg/kg) significantly reduced the infarction to 29.4 ± 4.4% and 24.3 ± 3.5% of the coronal sections, respectively, compared to vehicletreated control rats (50.3 ± 2.2%). MK-801 (1 mg/kg, i.p.) also markedly reduced the infarct volume. Animal body temperatures were monitored for 6 h after cerebral reperfusion commenced, and no significant differences were observed between the SCR and control groups (data not shown). Thus, the observed neuroprotective effects of SCR were not attributable to hypothermic effects.
Similarly, the neurological deficit scores were also significantly reduced to 1.00 ± 0.38 and 0.63 ± 0.26 in animals treated with 30 and 50 mg/kg of SCR, respectively, compared to vehicle-treated rats that scored 1.88 ± 0.35 (Fig. 5) .
Neuroprotective effect of SCR on MCAO-induced neuronal death
MCAO produced neuronal death in the cortex, striatum, and hippocampus, which plays a major role in learning and memory. The histological changes caused by MCAO in the cortex (A, B, and C), hippocampus (D, E, and F), and pyramidal cell layer of the CA3 region of the hippocampus (G, H, and I) are shown in Fig. 6 . Sham-operated rats did not exhibit histological changes (Fig. 6: A, D, and G) , but the brain tissues of the cortex and hippocampus of vehicle-treated controls showed marked neuronal damage shrunken cell bodies, perineuronal vacuolation, and pyknotic nuclei (Fig. 6 : B, E, and H). Neuronal damage occurred predominantly in the CA3 region of the hippocampus (Fig. 6H) . The MCAO-induced neuronal cell damage, regardless of brain region, was reduced by treatment with SCR (50 mg/kg) (Fig. 6: C, F, and I ).
Discussion
Most of the previous hypotheses dealing with neuro- degenerative disease have invoked abnormal release and/or decreased reuptake of the excitatory amino acid glutamate as playing a key role in excitotoxicity. Neuronal death in conditions such as ischemia, cerebral trauma, or the action of neurotoxins appears to be mediated at least in part by the extensive release of glutamate and its interaction with receptors (5). Activation of NMDA receptors elevates the influx of Ca 2+ and that of non-NMDA glutamate receptors promotes the influx of Na + , both of which can lead to membrane depolarization. In turn, depolarization can activate plasma membrane voltage-sensitive Ca 2+ channels, leading to additional Ca 2+ influx. NMDA-induced elevation of [Ca 2+ ] i plays a fundamental role in the process of excitotoxicity (8, 25 ] i triggers downstream events including elevation of cGMP, glutamate release, and activation of nitric oxide synthase (NOS) (26, 27) . Released glutamate acts on glutamate receptors and thereby potentiates the neurotoxicity. Ca 2+ channel antagonists and NMDA-receptor antagonists such as MK-801 reverse these conditions (28, 29) .
In the present study, long-term treatment with NMDA resulted in neuronal death in cultured rat cortical neurons, in accordance with many previous reports.
NMDA also caused significant increases in [Ca
2+
] i and ROS. In previous studies, we demonstrated that NMDAinduced neuronal death, as well as increases in [Ca 2+ ] i and ROS generation, were completely reversed by MK-801, indicating that the neurotoxicity was mediated by the activation of the NMDA-type glutamate receptors (30, 31) . SCR, over a concentration range of 10-50 µg/ml, protected neurons against NMDA-induced cell death. SCR also blocked the NMDA-induced increases in [Ca 2+ ] i and ROS generation. Elucidation of the events occurring downstream of neuronal Ca 2+ overloading requires further research. ROS generation undoubtedly occurs during glutamate neurotoxicity and is likely due to Ca 2+ influx into the cytosol (32) . Many reports have demonstrated that Ca 2+ signals activate enzymes that are associated with ROS generation (e.g., xanthine oxidase, NOS, and phospholipase A 2 ), leading to lipid peroxidation and neuronal damage (9, 10) . Ionotropic glutamate-receptor agonists increase the rate of ROS formation (33, 34) , and extended treatment with glutamate results in permanent damage to mitochondria and uncoupling, which occurs simultaneously with elevated mitochondrial ROS production. Cytosolic Ca 2+ deregulation is followed by membrane permeability transitions (35) , but whether SCR suppresses ROS generation by inhibiting the [Ca
] i increase, or vice versa, was not determined in this study. The neuroprotective effects of SCR were hypothesized to be primarily due to the inhibition of NMDA-induced elevation of [Ca 2+ ] i , as shown for many compounds that have CNS inhibitory activities due to their inhibition of neuronal depolarization, and inhibition of the Ca 2+ increase then inhibited ROS generation.
Excitotoxicity through overactivation of NMDA receptors is well established as an important trigger of tissue damage in focal cerebral ischemia (34, 36) and is consistent with our data showing that ischemia-induced infarct was blocked by the NMDA-receptor antagonist MK-801. SCR showed prominent inhibitory effects on NMDA-induced neuronal cell death, [Ca 2+ ] i elevation, and ROS generation in cultured neurons. Therefore, we hypothesized that SCR could prevent ischemia-induced brain damage. The rat MCAO model with reperfusion mimics many features of stroke in humans, since the middle cerebral artery, which is the specific occlusion site in this model, is the most commonly affected vessel in both embolic and thrombotic stroke in humans (37, 22) . Using the rat MCAO model, the present study demonstrated that SCR is a potent neuroprotectant in transient brain ischemia. In addition to the in vitro neuroprotective effects of SCR, SCR effectively decreased the infarct volume in the brain in the in vivo rat MCAO model. This result was supported by an attenuation of the MCAO-induced neurological deficits when animals were administered SCR. Moreover, SCR treatment significantly prevented MCAO-induced neuronal damage in the cerebral cortex and hippocampus, as observed by histological examination.
Among the six compounds isolated from SCR, oxyresveratrol and resveratrol showed protective effects against NMDA-induced neuronal cell death. These compounds were able to reduce the NMDA-induced [Ca
] I increase and ROS generation and, as a result, were able to attenuate neuronal death in primary cultures of rat cortical neurons. Oxyresveratrol and resveratrol are polyphenolic antioxidants found in a wide variety of plant species. Resveratrol has previously been demonstrated to be effective against cerebral ischemic injury (38 -41) and kainic acid-induced seizures and neurotoxicity in rodents (42, 43) . Furthermore, in a recent study, trans-resveratrol suppressed excitatory synaptic transmission in the hippocampal CA1 region through inhibition of postsynaptic glutamate receptors (13) . Therefore, the prevention of MCAO-induced cerebral ischemic injury by SCR may be attributable to the beneficial effects of resveratrol and oxyresveratrol.
Hypoxic / ischemic insults to the brain cause not only excitotoxicity that leads necrosis of neurons, but also oxidative stress that results in delayed neuronal cell death (34, 44) . Most of the neuroprotective actions of resveratrol are associated with its intrinsic radical scavenger properties (40, 42, 45) . In addition to antioxidant actions, various mechanisms for neuroprotection by the resveratrols have been proposed, including activation of PKC (46) and the nuclear hormone receptors PPARα/γ (39), as well as suppression of caspase-7 activity (47) and NF-κB DNA binding (48 In conclusion, resveratrol and oxyresveratrol as active components of SCR may be responsible for the neuroprotective effects of SCR against ischemia-induced brain damage in vivo and NMDA-induced neurotoxicity in vitro. SCR protection against excitotoxic brain damage suggests that it may prove to be a promising agent for the treatment of neurodegenerative disorders such as stroke. ment Administration, Republic of Korea and the Brain Korea 21 Project.
